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The cellular DEAD-box protein DDX3 was recently shown to be essential for hepatitis C virus
(HCV) replication. Prior to that, we had reported that HCV core binds to DDX3 in yeast-two hybrid
and transient transfection assays. Here, we confirm by co-immunoprecipitation that this
interaction occurs in cells replicating the JFH1 virus. Consistent with this result,
immunofluorescence staining of infected cells revealed a dramatic redistribution of cytoplasmic
DDX3 by core protein to the virus assembly sites around lipid droplets. Given this close
association of DDX3 with core and lipid droplets, and its involvement in virus replication, we
investigated the importance of this host factor in the virus life cycle. Mutagenesis studies located a
single amino acid in the N-terminal domain of JFH1 core that when changed to alanine
significantly abrogated this interaction. Surprisingly, this mutation did not alter infectious virus
production and RNA replication, indicating that the core–DDX3 interaction is dispensable in the
HCV life cycle. Consistent with previous studies, siRNA-led knockdown of DDX3 lowered virus
production and RNA replication levels of both WT JFH1 and the mutant virus unable to bind
DDX3. Thus, our study shows for the first time that the requirement of DDX3 for HCV replication is
unrelated to its interaction with the viral core protein.
INTRODUCTION
Persistent hepatitis C virus (HCV) infection is a major
cause of chronic hepatitis, cirrhosis and hepatocellular
carcinoma (HCC). Current treatments for chronic infec-
tion are ineffective in approximately 50% of patients
(Chen & Morgan, 2006). The virus, which belongs to the
family Flaviviridae, has a positive-sense RNA genome
encoding a polyprotein that is cleaved by cellular and viral
proteases to yield mature structural and non-structural
proteins. The structural proteins are core and the envelope
glycoproteins E1 and E2, while the non-structural proteins
are p7, NS2, NS3, NS4A, NS4B, NS5A and NS5B (reviewed
by Moradpour et al., 2007). HCV exhibits a high degree of
genetic variability with six distinct viral genotypes, each
further divided into subtypes, and within a single
individual the virus exists as a constantly evolving
quasispecies (Bukh et al., 1995; Pawlotsky, 2003;
Simmonds, 1995).
HCV core is a highly conserved basic, RNA-binding
protein that forms the viral nucleocapsid (McLauchlan,
2000). Mature core is a dimeric, alpha-helical protein that
can be separated into two domains (D1 and D2) based on
its hydropathic profile (Boulant et al., 2005; McLauchlan,
2000). The N-terminal hydrophilic D1 domain consists of
the first 117 aa and is mainly involved in RNA binding and
oligomerization of the core protein (Boulant et al., 2005). Supplementary figures are available with the online version of this paper.
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(McLauchlan, 2000). The hydrophobic D2 domain, which
spans amino acid residues 118 to approximately 169, is
required for correct folding of D1. D2 consists of two
amphipathic a-helices connected by a hydrophobic loop
and mediates core association with lipid droplets (LDs)
and endoplasmic reticulum membranes (Barba et al., 1997;
Boulant et al., 2006; Hope & McLauchlan, 2000). Recent
evidence strongly suggests that the HCV core–LD asso-
ciation is important for the production of infectious virus
particles (Boulant et al., 2007; Miyanari et al., 2007;
Shavinskaya et al., 2007).
We and others previously showed that the core domain D1
interacts with the cellular DEAD-box RNA helicase DDX3
(Mamiya & Worman, 1999; Owsianka & Patel, 1999; You
et al., 1999). In mammalian cells, DDX3 is present
throughout the cytoplasm and can also be found in the
nucleus. Ectopic expression of HCV core in these cells
results in the redistribution of a proportion of DDX3 to
distinct cytoplasmic sites, where it co-localizes with core.
Indeed, DDX3 was recently shown to be present on LDs in
core-expressing Hep39 cells (Sato et al., 2006).
Cellular RNA helicases of the DEAD-box family participate
in all biological processes involving RNA. They possess
nine conserved motifs (see Fig. 1), including motif II (Asp–
Glu–Ala–Asp or DEAD) after which the protein family is
named (reviewed by Cordin et al., 2006; Rocak & Linder,
2004). DDX3 is a ubiquitous cellular protein, possessing
ATPase and helicase activities (Franca et al., 2007; Yedavalli
et al., 2004). Known homologues include murine PL10
(Leroy et al., 1989), Xenopus laevis An3 (Gururajan et al.,
1991) and yeast Ded1 (Jamieson & Beggs, 1991). The exact
cellular function of DDX3 has yet to be defined, but there is
evidence for its involvement in splicing (Deckert et al.,
2006; Zhou et al., 2002), translation initiation and
repression (Beckham et al., 2008; Shih et al., 2008), cell
cycle regulation (Chang et al., 2006; Chao et al., 2006;
Huang et al., 2004; Sekiguchi et al., 2007), nucleo-
cytoplasmic RNA shuttling (Yedavalli et al., 2004), RNA
transport (Kanai et al., 2004), interferon induction
(Schroder et al., 2008; Soulat et al., 2008) and apoptosis
(Sun et al., 2008). Both upregulation and downregulation
of DDX3 have been reported in various tumour tissues,
suggesting divergent roles of DDX3 in cancer-related
pathogenesis (Botlagunta et al., 2008; Chang et al., 2006;
Chao et al., 2006; Huang et al., 2004).
Previously, we proposed that the HCV core–DDX3
interaction might function in virus replication and/or
pathogenesis (Owsianka & Patel, 1999). Two separate
studies recently provided evidence for the involvement of
DDX3 in HCV replication (Ariumi et al., 2007; Randall
et al., 2007). The importance of DDX3 in the life cycle of
other viruses has also become apparent, including its
requirement for human immunodeficiency virus-1 (HIV-
1) replication (Yedavalli et al., 2004). Furthermore, the
DDX3 homologue Ded1 is required for brome mosaic virus
replication (Noueiry et al., 2000). In contrast, DDX3
inhibits hepatitis B virus transcription by its incorporation
into nucleocapsids (Wang et al., 2009). Thus, there is
increasing evidence that DDX3 is important in the life cycle
of several diverse viruses.
The direct relevance of the core–DDX3 interaction for the
HCV life cycle has not yet been elucidated. In this study, we
show that this interaction does occur in cultured cells
infected with HCV strain JFH1 (Wakita et al., 2005), and
that DDX3 co-localizes directly with core on LDs. Using
alanine substitution mutagenesis, we identified a key
amino acid residue within the D1 domain of core that is
Fig. 1. Generation of anti-DDX3 antibodies.
(a) Schematic representation of DDX3 protein
structure showing the nine conserved motifs,
including motif II (or the DEAD motif). The
arrows mark the epitopes recognized by the
mouse mAbs. (b) Characterization of anti-
DDX3 antibodies. HuH-7 cell lysates were
immunoprecipitated with the immune (I) and
pre-immune (PI) antiserum R648, or mAb
AO196 or an isotype control mAb. The
immune complexes were analysed by
Western blotting using biotinylated R648.
Positions of molecular mass markers are
shown (in kDa). (c) Western blotting of HuH-
7 cell lysates with R648-I, -PI, mAb AO196
and isotype control mAb. (d) Western blotting
of lysates of HEK cells transfected with a
plasmid expressing EGFP alone or an EGFP–
DDX3 fusion protein using anti-GFP mAb,
AO196 and R648.
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impact of abrogation of the core–DDX3 interaction on
virus RNA replication and infectious progeny yields in
cultured cells.
RESULTS
Generation of DDX3 antibodies
We previously showed that DDX3 co-localizes with HCV
genotype 1a core in cytoplasmic punctate spots (Owsianka
& Patel, 1999). To better understand the nature of this
interaction, we generated several mouse mAbs (prefixed
with ‘AO’, see Fig. 1a) and two rabbit polyclonal antisera
(R647 and R648) to human DDX3. Both rabbit antisera
and the majority of mAbs were found to interact with
DDX3 by ELISA, Western blotting and immunoprecipita-
tion assays (data not shown). The epitopes of mAbs
reactive to DDX3 in Western blots were broadly mapped
using truncated forms of DDX3 expressed in bacteria as
GST-fusion proteins. Most of the mAbs recognized aa 409–
473, a region located between motifs III and V of DDX3,
whereas mAb AO190 recognized motifs V and VI. mAbs
AO166 and AO196 bound to the N-terminal region,
whereas mAbs AO2 and AO35 recognized the region
downstream preceding the ATPase domain of DDX3
(Fig. 1a).
The specificities of antibodies AO196 and R648 for DDX3
in immunoprecipitation and Western blot assays are shown
in Fig. 1(b, c, d). The polyclonal serum R648 (but not the
pre-immune control serum) specifically immunoprecipi-
tated DDX3 from a cytoplasmic extract of HuH-7 cells, as
did mAb AO196 (Fig. 1b). R648 and AO196 also
recognized DDX3 in cytoplasmic extracts of HuH-7 cells
by Western blotting (Fig. 1c). The specificity of these
antibodies was further demonstrated by their recognition
of both endogenous DDX3 and an enhanced green
fluorescent protein (EGFP)–DDX3 fusion protein
expressed in HEK cells (Fig. 1d). mAb AO196 and R648
recognized only the cytoplasmic form of DDX3 by
immunofluorescence (Fig. 2a and data not shown), even
though they were able to detect DDX3 in the nuclear
extracts of cells in both immunoprecipitation and Western
blotting assays (data not shown). In contrast, another mAb
Fig. 2. Sequestration of DDX3 by HCV core.
(a) DDX3 co-localizes with core in JFH1-
infected cells. HuH-7 cells were either mock-
infected (lower panel) or infected with JFH1
(top panel). At 3 days post-infection, cells were
fixed and probed with HCV core and DDX3
using antibodies R308 and A0196, respect-
ively. Cell nuclei were detected by counter-
staining with DAPI. (b) Co-immunoprecipitation
of core by anti-DDX3 antiserum. HuH-7 cells
electroporated with viral RNA were lysed at
72 h post-incubation, and the lysate immuno-
precipitated with anti-DDX3 R648 immune (I)
or pre-immune (PI) serum. The resulting pre-
cipitates were examined by immunoblotting
using anti-core mAb c7-50 (top panel). One
twentieth of the cell lysate used in the co-
immunoprecipitation assay was immunoblotted
for core with mAb c7-50 as the input control
(bottom panel). (c) Localization of DDX3 and
core on LDs. HuH-7 cells electroporated with
the JFH1WT RNA were fixed at 72 h post-
transfection and probed using antibodies to
core (R308), DDX3 (AO196) and ADRP. Z-
stack analysis of all three proteins was per-
formed by recording a series of approximately
20 images. 3D reconstructions of the boxed
areas are shown (i) and a selected area is
shown in greater detail (ii) where DDX3 is
depicted as a wire frame to reveal the core–
ADRP association. Bars, 10 mm for confocal
images and 2 mm for 3D image.
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nuclear form of DDX3 by immunofluoresence (Supple-
mentary Fig. S1a).
HCV core interacts with cellular DDX3 in cells
replicating WT JFH1
The core–DDX3 interaction was previously demonstrated
in cells ectopically expressing HCV genotype 1a core, and
in the absence of virus RNA replication and productive
infection (Owsianka & Patel, 1999). To test whether DDX3
interacts with JFH1 core, HuH-7 cells transfected with
virus RNA were first analysed by indirect immunofluores-
cence. DDX3 was found to be sequestered by core in JFH1-
replicating cells as detected using mAbs AO196 and AO322
[Fig. 2a and Supplementary Fig. S1a (available in JGV
Online), respectively]. It should be noted that the core-
bound DDX3 emitted a stronger fluorescent signal
compared with free DDX3 occupying the cell cytoplasm.
Thus, adjustment of the core-bound DDX3 signal to
prevent overexposure resulted in the apparent loss of free
DDX3 from the image. A representative image of core and
DDX3 in virus-infected and surrounding non-infected
cells taken at two different intensities is shown in
Supplementary Fig. S1(b) (available in JGV Online). The
anti-DDX3 antiserum R648 specifically co-immunopre-
cipitated core from JFH1-replicating cells, further con-
firming a direct interaction between these two proteins
(Fig. 2b).
We also found that DDX3 co-localized with core protein in
the NNeo/C-5B(+) cell line harbouring an autonomously
replicating genome-length genotype 1b RNA (Ikeda et al.,
2002), and HuH-7 cells infected with the intergenotypic
1a/2a chimeric virus [H-NS2/NS3 J(YH/QL)] (Yi et al.,
2007) (Supplementary Fig. S1c, d, available in JGV Online).
Thus, the recruitment of DDX3 by core is in good
agreement with our previous results (Owsianka & Patel,
1999), and is not limited to one virus genotype.
DDX3 interacts with HCV core on LDs
The association of HCV core with LDs is essential for
infectious virus production (Boulant et al., 2007; Miyanari
et al., 2007; Shavinskaya et al., 2007). We sought to gain
further insight into the core–DDX3 complex in the context
of the JFH1 system by analysing the intracellular distri-
bution of core and DDX3. HuH-7 cells electroporated with
JFH1 RNA were analysed by indirect immunofluorescence
for HCV core, DDX3 and adipocyte differentiation-related
protein (ADRP), a protein abundant on the surface of LDs
(Fujimoto et al., 2004). As shown in Fig. 2(c) left, core
associated with ADRP and the localization of DDX3 was
precisely coincident with both proteins, indicating its
redistribution to LDs. To examine the subcellular position
of DDX3 and core in relation to ADRP in greater detail, a
series of Z-stacks was obtained and used after blind
deconvolution to create a three-dimensional model of LDs
coated by core, ADRP and DDX3. As reported before
(Boulant et al., 2007), core fully coated LDs. We found that
DDX3 by virtue of its interaction with core was also fully
associated with LDs [Fig. 2c (i) and (ii)].
Identification of core residues required for DDX3
interaction
We previously reported that aa 1–59 of core protein are
involved in its interaction with DDX3 (Owsianka & Patel,
1999). To identify critical residues within this region, a
library of core 1–59 mutants containing single or multiple
amino acid substitutions was generated by error-prone
PCR (EP-PCR). The mutated sequences were fused in-
frame with GFP and expressed in bacteria. The mutant
fusion proteins were screened by incubation with GST–
DDX3 fusion protein immobilized in ELISA wells, and the
bound mutants detected using a rabbit polyclonal anti-GFP
antiserum. Of 130 clones screened, only nine were found to
be defective in binding to GST–DDX3 (data not shown). In
order to confirm these results, all nine mutants were
individually subcloned into a sequence encoding the HCV
genotype 1a strain H77c core, E1 and E2 (pCE1E2) in a
mammalian expression vector pcDNA3.1/Zeo+ (Invitro-
gen), and their expression was analysed by indirect
immunofluorescence. The results were in accordance with
the data from the initial ELISA screen in that all nine
mutated core proteins failed to redistribute DDX3 (data
not shown). Nucleotide sequence analysis showed that each
of the mutants carried between one and four amino acid
substitutions (Fig. 3). Of interest, mutant 90 had only one
substitution (I30N), indicating that this residue must be
required for the interaction of core with DDX3. All nine
mutant proteins had at least one amino acid substitution in
the region spanning residues 24–36, indicating that this
region may harbour residues that are critical for the core–
DDX3 interaction. To test this hypothesis, site-directed
mutagenesis was carried out to revert any mutations
outside of this 13 aa region back to the WT residue. These
new mutant core 1–59 fragments were then subcloned into
pCE1E2, and their expression analysed following transient
transfection into HuH-7 cells as above. Again, none of
these new core mutants redistributed DDX3 (data not
shown), indicating that the 13 aa region between residues
24 and 36 of core is indeed involved in the interaction
between core and DDX3. To determine which residues in
this 13 aa region were essential, we carried out alanine-
scanning mutagenesis across aa 24–36, individually substi-
tuting each residue in this region with alanine. As before,
these alanine mutant sequences were subcloned into
pCE1E2 and transiently transfected into HuH-7 cells.
Immunofluorescence analysis revealed seven mutants
(P25A, G26A, G28A, Q29A, V31A, G32A and L36A) that
showed distinct co-localization between core and DDX3
(similar to that seen with WT HCV core), whilst the other
mutants (F24A, G27A, I30A, G33A, V34A and Y35A)
displayed no interaction with DDX3 at all (Supplementary
Fig. S2, available in JGV Online). Thus, these results
HCV core–DDX3 interaction
http://vir.sgmjournals.org 125indicate that core residues F24, G27, I30, G33, V34 and Y35
are critical for its interaction with DDX3.
Disrupting the core–DDX3 interaction
Sequence comparison of core protein from strains H77c
(genotype 1a) and JFH1 (genotype 2a) revealed 96.6%
identity within the first 59 residues of core, with the key
residues (F24, G27, I30, G33, V34 and Y35) for interaction
with DDX3 being fully conserved (data not shown). Thus,
recombinant JFH1 genomes each containing one of the six
mutations were constructed. All mutants were replication
competent as seen by the expression of NS5A protein at
3 days post-transfection (Fig. 4). The viral core protein in
these cells was detected using two different anti-core
antibodies, which bound to the mutant proteins with
varying affinity. mAb c7-50 bound minimally or not at all
to I30A and G33A mutants, but had increased affinity for
the V34A protein. The anti-core rabbit serum R308 on the
other hand recognized all core forms equally except for
G33A (Fig. 4). Notably, all six core mutations are located
within the epitope (aa 21–40) recognized by c7-50
(Moradpour et al., 1996), which may account for the
altered affinity of this mAb to some mutants. The
antiserum R308 was raised against a peptide corresponding
to core aa 5–25 (Hope & McLauchlan, 2000). Therefore,
the smaller quantities of G33A core detected using R308
suggest either this mutation lowers the stability of the
protein or simply reduces the binding efficiency of the
antibody. Importantly, there was no detectable change in
DDX3 protein levels in any of the transfected cell cultures
tested (Fig. 4).
We next tested by co-immunoprecipitation if these
mutations had effectively disrupted the core–DDX3
interaction in virus-replicating cells. We excluded mutants
I30A, G33A and V34A from this assay due to their altered
affinity to mAb c7-50 (Fig. 4), which is the antibody we
found to be most compatible in our co-immunoprecipita-
tion assay. As shown in Fig. 5, the F24A and G27A core
mutants were co-immunoprecipitated by the anti-DDX3
antiserum R648 in much lower amounts than the WT
protein. However, the Y35A core was not co-immunopre-
cipated at all, indicating that its interaction with DDX3 was
abrogated. Consistent with these findings, no co-local-
ization of core and DDX3 was seen in cells replicating
JFH1Y35A by immunofluoresence analysis (Fig. 5b).
Importantly, this mutant core remained associated with
LDs, which is not surprising since motifs responsible for
targeting core to LDs are located in the D2 domain (Hope
& McLauchlan, 2000).
HCV replication in the absence of the core–DDX3
interaction
To determine the importance of this interaction in the
virus life cycle, we examined the phenotype of JFH1Y35A.
Fig. 3. Identification of core residues critical for its interaction with DDX3. Amino acid substitutions in residues 1–59 of core in
nine mutants unable to interact with DDX3. Residues in the region 24–36 (shaded box) were targeted for alanine-scanning
mutagenesis, which identified residues at positions 24, 27, 30, 33, 34 and 35 (underlined in the sequence at the top) that were
critical for DDX3 interaction.
Fig. 4. Analysis of JFH1 core mutant viruses. HuH-7 cells
electroporated with viral RNAs as shown were subjected to
Western immunoblotting at 72 h post-incubation using anti-NS5a
mAb 9E10, anti-core antibodies mAb c7-50 or R308, anti-DDX3
mAb AO196 and an anti-tubulin antibody.
A. G. N. Angus and others
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the replication-deficient JFH1GND RNAs and incubated for
various time points before determining the progeny virus
yields released into the medium and intracellular viral RNA
levels. As shown in Fig. 6(a), the number of infectious
particles released by JFH1Y35A-replicating cells was lower in
comparison with JFH1WT-transfected cells at 24 and 48 h
post-transfection, although parity was achieved at 72 h.
The intracellular RNA replication levels of JFH1Y35A were
similar to JFH1WT throughout the time-course (Fig. 6b).
As expected, no virus release or intracellular viral RNA
replication was detected in cells harbouring JFH1GND RNA
(Fig. 6a, b). We next examined the infectivity and
replication of the core mutant virus released from
electroporated cells. To do this, we infected naı ¨ve cells at
an equal m.o.i. and quantified the released infectious virus
progeny and the intracellular viral RNA at various times
post-infection. As shown in Fig. 6(c, d), respectively, both
the virus yields and RNA replication levels of JFH1Y35A
were very similar to JFH1WT. We found no direct reversion
or second-site mutation in JFH1Y35A core sequence. Thus,
our data indicate that the core–DDX3 interaction does not
play a role in HCV morphogenesis.
Replication of HCV following siRNA-mediated
knockdown of DDX3
Recent reports have shown that siRNA-mediated knock-
down of DDX3 reduces JFH1WT replication in infected
cells (Ariumi et al., 2007; Randall et al., 2007). To assess the
influence of DDX3 abundance on virus infection in the
absence of the core–DDX3 interaction, we measured the
replication of JFH1WT and JFH1Y35A following infection of
Fig. 5. Analysis of the interaction of DDX3 with core mutants. (a)
HuH-7 cells were electroporated with different viral RNAs and
HCV core co-immunoprecipitated at 72 h post-incubation using
the anti-DDX3 serum R648 as described in the legend to Fig. 2b.
(b) HuH-7 cells electroporated with JFH1Y35A were fixed at 72 h
post-incubation and analysed by confocal microscopy for the
intracellular distribution of core, DDX3 and ADRP using appropri-
ate antibodies. Bar, 10 mm.
Fig. 6. Analysis of the core mutant viruses. (a,
b) Determination of virus yield and intracellular
RNA levels following transfection. HuH-7 cells
were electroporated with RNA derived from
JFH1WT, JFH1Y35A or JFH1GND cDNA. At the
indicated time points (a) the released virus
titres and (b) the intracellular HCV RNA levels
were quantified by TCID50 and RT-qPCR,
respectively. (c and d) Determination of virus
yield and intracellular RNA levels following
infection. Naı ¨ve HuH-7 cells were infected with
JFH1WT or JFH1Y35A (obtained from the
electroporated cells above) at an m.o.i. of
0.02. The (c) titres of infectious virus released
into the medium and (d) intracellular viral RNA
levels were measured over 6 days as
described above. Means and error ranges
from duplicate electroporations and infections
are shown.
HCV core–DDX3 interaction
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DDX3 (Fig. 7a). As previously described, DDX3 knock-
down cells were substantially less permissive for virus
replication than normal cells following infection with
JFH1WT. Similar reductions in JFH1Y35A replication levels
were also observed (Fig. 7b). Collectively, the data
presented in Figs 6 and 7 indicate that DDX3 promotes
efficient HCV infection by processes that are independent
of its interaction with the viral core protein.
DISCUSSION
The recent advent of the HCV cell culture system has
enabled us to further characterize the core–DDX3 inter-
action in the context of the complete HCV life cycle. Our
overall goal is to deduce the role of DDX3 in normal cells
with a view to understanding the significance of its
interaction with HCV core in the virus life cycle and
pathogenesis. Towards this end, we generated a large panel
of mAbs recognizing different regions of DDX3. Using a
subset of these, we confirmed that this interaction is
genuine in JFH1-infected cells.
Given the putative function of DDX3 in RNA metabolism,
initial identification of the core–DDX3 interaction led us
and others to postulate its possible role in virus replication
and assembly (Mamiya & Worman, 1999; Owsianka &
Patel, 1999; You et al., 1999). Recent data using the JFH1
system suggest that HCV RNA replication and virus
assembly occur in LD-associated membranes (Boulant
et al., 2007; Miyanari et al., 2007). Core protein, which
associates with LDs (McLauchlan, 2000; Roingeard &
Hourioux, 2008), recruits the viral non-structural proteins,
replication complexes and envelope glycoproteins to these
sites, allowing virus assembly to proceed in this local
environment (Miyanari et al., 2007). We show here that
core also recruits the cellular DDX3 to LDs, suggesting that
it may have a function in HCV replication. In keeping with
this, two recent studies have shown reductions in JFH1
replication when DDX3 is removed from the cell by siRNA
(Ariumi et al., 2007; Randall et al., 2007). We hypothesized
that disrupting the association between HCV core and
DDX3 might be detrimental to HCV replication, and
provide insights into the purpose of this interaction. Our
mutagenesis analysis revealed that the Y35A substitution in
the JFH1 core molecule abrogated this interaction without
affecting core–LD association. No alteration to virus RNA
replication, translation or infectious particle production
was observed following transfection of this mutant viral
RNA into the cells. Similarly, JFH1Y35A virus yields from
cells infected with the mutant progeny were equivalent to
those of the WT virus. Interestingly, the two other mutants
identified in this study (JFH1F24A and JFH1G27A) showed
greater reductions in virus replication, particularly post-
infection (Supplementary Fig. S3, available in JGV Online).
However, given their interaction with DDX3 is only slightly
reduced (Fig. 5), this impairment is unlikely to be related
to the disruption of the core–DDX3 interaction. A more
plausible explanation for their unusual phenotypes could
be an alteration in core function and/or RNA structure
resulting from an alanine substitution at these positions,
and as such these mutants require further investigations.
Nevertheless, our results collectively suggest that the core–
DDX3 interaction plays no role in virus morphogenesis.
Subgenomic replicons that do not possess core replicate as
well as, if not better than, replicons encoding the entire
polyprotein (Blight et al., 2000; Ikeda et al., 2002; Lohmann
et al., 1999), which indicates that the core–DDX3
interaction per se is not essential for HCV RNA replication.
Nevertheless, Ariumi et al. (2007) reported that subge-
nomic replicons showed a twofold decrease in RNA
replication in DDX3 knockdown cells. This finding raises
an intriguing prospect that DDX3 may play a direct role in
HCV RNA replication independent of and in addition to
its interaction with core. Nonetheless, these workers
observed a much greater reduction in JFH1 RNA
replication in cells supporting replication of full genome-
length RNAs, indicating greater importance of DDX3 in
this setting and supporting the functional relevance of the
interaction of DDX3 with core. We reproduced the
deleterious effects of DDX3 knockdown on the JFH1WT
replication but also found a similar phenotype for
JFH1Y35A (Fig. 7). This finding further supports the notion
of the core–DDX3 interaction having no function in HCV
replication. Therefore, our data make a clear distinction
between the effects of siRNA knockdown of DDX3 from
the cells and disruption of the core–DDX3 interaction on
HCV replication.
The possible involvement of the core–DDX3 interaction in
pathogenesis cannot be discounted. Indeed, core protein
has been widely implicated in modulating cellular func-
tions, mainly due to its interaction with numerous host
Fig. 7. Infection of DDX3 knockdown cells. (a) HuH-7 cells were
transfected with siRNA duplexes as indicated. Cells were
harvested after 2 days and examined by Western blotting using
the anti-DDX3 mAb AO196. (b) Naı ¨ve and DDX3-deficient HuH-7
cells were infected with WT JFH1WT or JFH1Y35A virus. At 2 days
post-infection the levels of released virus and intracellular HCV
RNA were measured by TCID50 assay and RT-qPCR, respectively.
Means and error ranges from duplicate infections are shown.
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Shimotohno, 2003). Differential regulation of DDX3 has
been reported in a number of tumours, including HCC,
suggesting that it may be involved in HCV-associated
pathogenesis (Botlagunta et al., 2008; Chang et al., 2006;
Chao et al., 2006; Huang et al., 2004). DDX3 is also one of
several DEAD-box proteins that are upregulated during
HIV-1 replication (Krishnan & Zeichner, 2004). Interest-
ingly, it is also upregulated during immune response to
lipopolysaccharide-induced inflammation and during
interferon treatment (de Veer et al., 2001; Saban et al.,
2006). Thus, it is possible that during active viral
replication HCV recruits DDX3 protein to evade host
immune recognition, thereby adversely affecting one or
more of its roles in normal cells (Rosner & Rinkevich,
2007) and in turn contributing to viral pathogenesis.
Although we observed no differences in DDX3 expression
levels between JFH1-infected cultured cells and uninfected
cells, its relevance in vivo from a long-term disease
perspective warrants further investigation.
METHODS
Cell culture and antibodies. Human hepatoma HuH-7
(Nakabayashi et al., 1982) cells were propagated as described
previously (Witteveldt et al., 2009). The anti-NS5A mouse mono-
clonal antibody (mAb) 9E10 was a kind gift from Charles M. Rice
(Center for the Study of Hepatitis C, The Rockefeller University, New
York, USA) (Lindenbach et al., 2005). The anti-HCV core rabbit
serum R308, and the anti-ADRP sheep serum have been described
previously (Hope & McLauchlan, 2000; Targett-Adams et al., 2003).
The anti-HCV core mAb c7-50 and the anti-a-tubulin and anti-GFP
mAbs were purchased from Bioreagents and Sigma, respectively.
Generation and characterization of anti-DDX3 antibodies.
BALB/c mice and rabbits were immunized with a bacterially expressed
glutathione S-transferase-full-length DDX3 (GST–DDX3) fusion
protein and antibodies generated essentially as previously described
(Clayton et al., 2002). A total of two rabbit polyclonal antisera (R647
and R648) and 16 mouse hybridomas secreting mAbs (see Fig. 1) to
DDX3 was generated. The mAbs were initially identified and selected
on the basis of their ability to interact with GST–DDX3, but not an
irrelevant GST fusion protein, in an ELISA assay (data not shown).
Plasmid constructs and mutagenesis. The full-length DDX3 gene
was cloned into the BamHI site, in-frame to sequences encoding the
EGFP, in the vector pEGFP-C1 (Clontech) to generate EGFP–DDX3
fusion protein.
To identify residues within the N-terminal 59 aa of HCV core that are
critical for interaction with DDX3, EP-PCR was performed to
introduce random mutations into the HCV genotype 1a strain H77c
(Yanagi et al., 1997) sequence encoding this region. The fidelity of
Taq polymerase was decreased by altering the relative dNTP
concentrations, using a high Mg
2+ concentration and including
Mn
2+ in the reaction as described previously (Pritchard et al., 2005).
The mutated sequences were cloned in-frame with (and downstream
of) green fluorescence protein (GFP) in the bacterial expression
vector pKK223-3 (Pharmacia) and the library of core 1–59 mutant–
GFP fusion proteins generated was screened in an in vitro DDX3-
binding assay as described in Results. Nucleotide sequencing
subsequently identified the mutations introduced by EP-PCR in the
clones of interest.
The plasmid pUC-JFH1 carries the full-length cDNA of the genotype
2a HCV strain JFH1 (Wakita et al., 2005). The plasmids pUC-GND
JFH1 and pUC-JFH1 DE1E2 are identical except that they carry the
GND mutation in the NS5B-encoding sequence, or an in-frame
deletion in the E1 and E2 sequences (Wakita et al., 2005). Site-
directed mutagenesis was carried out using the QuikChange-II kit
(Stratagene) to introduce alanine substitutions at the target sites in
core. Briefly, various alanine substitutions in the core-coding region
were individually introduced into the plasmid pGEM-T (Promega)
carrying nt 1–2614 (corresponding to the 59 UTR and core to E2
coding sequence) of HCV strain JFH1 using appropriate primers (the
sequences of which are available upon request). The presence of the
desired mutation in the resulting clones was confirmed by nucleotide
sequencing. Sequences carrying the appropriate mutation were
subcloned back into pJFH1-pUC to generate mutant viruses (see
below).
Generation of JFH1 virus and its mutated derivatives. Ten
micrograms of RNA synthesized in vitro using linearized plasmid
templates carrying the wild-type (WT) or mutated JFH1 genomic
cDNA was electroporated into HuH-7 cells as described previously
(Wakita et al., 2005). The electroporated cells were seeded into
appropriate tissue culture dishes and incubated at 37 uC. At the
indicated time period, the medium containing the infectious virus
progeny was filtered through a 0.45 mm pore-sized membrane and
infectivity determined as described below.
Determination of virus infectivity and RNA replication. Virus
titres in the culture supernatants were determined as TCID50
(Lindenbach et al., 2005) following immunostaining for NS5A. The
intracellular and extracellular HCV RNA content was measured by
reverse transcription-quantitative real-time-polymerase chain reac-
tion (RT-qPCR) as described previously (Witteveldt et al., 2009). To
determine virus replication after electroporation, cells transfected
with the respective transcript were seeded into 10 cm culture dishes,
incubated at 37 uC for 4 h and then trypsinized. Total RNA was
prepared from 1/15 of the trypsinized cells using the RNeasy kit
(Qiagen) to quantify viral RNA by qRT-PCR assay. The remaining
cell suspension was split 1:3 into three T25 flasks. Following
incubation at 37 uC for 24, 48 and 72 h, the infectious virus yields in
cell culture supernatants were determined by TCID50 assay and the
intracellular viral RNA levels quantified by RT-qPCR. To measure
virus replication after infection, 5.3610
3 naı ¨ve HuH-7 cells seeded
into six-well culture dishes were infected with virus at the indicated
m.o.i. Following incubation at 37 uC for 24, 48, 72, 96 and 144 h,
infectious virus yields and intracellular viral RNA levels were
determined as described above.
SDS-PAGE and Western blotting. Cell lysates were subjected to
SDS-PAGE followed by Western blotting using appropriate antibod-
ies as described previously (Clayton et al., 2002). The bound
antibodies were detected using enhanced chemiluminescence reagents
(Amersham).
Immunoprecipitation of DDX3. HuH-7 cells were washed with PBS,
lysed in lysis buffer (20 mM Tris/HCl pH 7.4, 20 mM iodoacetamide,
150 mM NaCl, 1 mM EDTA and 0.5% Triton X-100) and the lysate
was spun briefly to remove nuclei. The clarified cell lysates were
incubated with the anti-DDX3 antibodies as described in the text and
the immune complexes precipitated using protein G agarose beads
(Sigma). Following washes of the Sepharose beads, the immune
complexes were analysed by SDS-PAGE followed by Western blotting
using biotinylated R648 and anti-streptavidin-horseradish peroxidase
(HRP) conjugate.
Co-immunoprecipitation of HCV core protein. Approximately,
5610
6 HuH-7 cells electroporated with viral RNA were seeded into
HCV core–DDX3 interaction
http://vir.sgmjournals.org 129100 mm tissue culture dishes. At 72 h post-transfection, the cells were
washed and lysed in 0.5 ml lysis buffer (20 mM Tris/HCl, pH 7.4,
135 mM NaCl and 0.1% Triton X-100) supplemented with 50 mM
NAF, 5 mM Na3VO4 and 1 mM PMSF. The lysate was spun briefly to
remove nuclei. After pre-clearing, the clarified lysate was immuno-
precipitated overnight with protein G agarose beads that had been
pre-incubated with the anti-DDX3 antiserum R648. The beads
carrying the immune complex were spun at 2000 r.p.m. (microcen-
trifuge) for 2 min, washed three times with the lysis buffer and
subjected to non-reducing SDS-PAGE followed by Western blotting
using the anti-core mAb c7-50 and anti-mouse IgG-HRP conjugate.
Indirect immunofluorescence. Cells on coverslips were fixed in
methanol and probed with the indicated primary antibody for 1 h at
room temperature. After washing with PBS, cells were incubated with
anti-species antibodies conjugated with fluorescein isothiocyanate,
tetramethyl rhodamine isothiocyanate or Cy5 (Invitrogen) for 1 h
and then washed with PBS. The coverslips were examined with a Zeiss
Laser Scanning LSM510 META inverted confocal microscope (Carl
Zeiss) and the images analysed using LSM510 software. Three-
dimensional (3D) reconstructions were performed from Z-stack
images collected using optimum intervals. Image stacks were
deconvolved by 3D-blind deconvolution using Autodeblur software
(MediaCybernetics), and 3D reconstructions were generated as
described previously (Boulant et al., 2007; Targett-Adams et al.,
2008).
RNA interference. Two pre-validated siRNA duplexes (s4004 and
s4005, synthesized by Applied Biosystems) targeting different regions
of the human DDX3 and a negative control siRNA composed of a
scrambled sequence were used. Naı ¨ve HuH-7 cells plated overnight
were transfected with lipofectamine RNAiMax (Invitrogen) and
50 nM siRNAs according to the manufacturer’s protocol. The cells
were then incubated for a further 2 days prior to virus infection. The
efficiency of DDX3 knockdown was determined by immunoblotting
using mAb AO196.
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